Option chain shows key data for Sanofi's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sanofi.

Sanofi (OTC:SNYNF) Stock, Option Chain

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

News

Intraday Update

Markets

Movers

Trading Ideas

AAPL

ACDVF

ACGL

ACIA

ADBE

ADDYY

ADSK

ADUS

ADYYF

AFGC

AKAM

AMADY

AMRC

ANSS

APPF

APTO

ARDC

ASMIY

ASMVY

ATEYY

ATRC

BABA

BAYRY

BAGGER DAVE'S BURGER TAV by Bagger Dave's Burger Tavern, Inc.

BDVB

BKNG

BLDP

BMDPF

BRKR

BYCBF

BYDIF

CABO

CACI

CARCY

CCLAY

CCNTF

CCOEY

CDAY

CDDRF

CFFA

CFRX

CIGI

CLNXF

CNVVY

COLL

COPJF

COUP

CRBJY

CROX

CSIOF

CSLLY

CSWI

CSXXY

CTAC

CTXS

CUEN

DASTY

DEAC

DERM

DRTGF

DXCM

DYFSF

ECNCF

Stocks That Hit 52-Week Highs On Friday

AAVXF

AHCHY

AIQUY

ALFVY

ARES

ASGN

ASGTF

ASML

ASND

ATBYF

ATGN

ATXI

AUPH

AXAHY

AZMTF

BKFKF

BMRPF

BOLD

BOOT

BTBIF

BURBY

BXMT

CATM

CBRE

CGEN

CGPZF

CHNG

CHTR

CODI

CRUS

CSTL

CTRN

CWXZF

CYDY

DGDM

DIOD

DNNGY

DSDVY

EDPFY

EPAM

ESPR

Eaton Vance Tax-Advantaged Global Dividend

EXPGY

FBMS

FERGY

FFMR

FGBI

FICO

AACAY

AAUKF

ABCZY

ACLS

AGRO

AHEXY

AHFD

AINV

ALGT

AMGN

AMIGF

AMIGY

AMKBF

AMRN

AMTB

ANSLF

APAM

ARGKF

ARGX

ARNC

AROW

ASBFY

ASNB

ASPN

ATDRY

ATLKY

ATVI

AXSM

BAESY

BANF

BBSEY

BCKIF

BCLYF

BNPQY

BNTX

BPOP

BRBR

BRK-A

BRK-B

BRKL

BTDPY

BTLCY

BTSGY

CARO

CBSH

CDUAF

CHDN

CIFAF

CLSD

CNOB

CODGF

CODYY

COHU

CRAI

CRD-A

CREIY

CRHCF

Stocks That Hit 52-Week Highs On Tuesday

Sanofi SA

Leerink Partners analyst David Risinger has reiterated their bullish stance on SNYNF stock, giving a Buy rating yesterday. David Risinger has given...

Promising Potential: Sanofi's Strong Pipeline and Strategic Market Focus Drive Buy Rating

Cytokinetics (CYTK) announced that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals fo...

Sanofi to acquire rights to develop, commercialize aficamten from Corxel

Sanofi to buy China rights to Cytokinetics lead asset

Duvakitug And Teva's Growth: A Game Changer In Pharma

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF – Research Report) and Cencora (COR – ...

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Cencora (COR)

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €115.00. The compan...

Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNYNF)

Vir jumps after Phase 1 data for Sanofi-partnered cancer drug technology

Nurix Therapeutics: Speculative Bet On BTK Degraders And Targeted Protein Modulation

Comments

Sanofi

Sanofi (SNYNF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga